Germany bans 80 generic drugs for insufficient trials by GVK – Livemint
0
Germany’s drug regulator has banned the sale of 80 generic medicines with immediate effect on the grounds that their clinical trials conducted by India’s pharmaceutical research company GVK Biosciences were “insufficient”.
The Federal Institute for Drugs and Medical Devices said on Tuesday it had ordered drug manufacturers, wholesale dealers, medical stores and other outlets not to sell or use these medicines any longer.
Read more – Livemint